Nektar Therapeutics is poised for a critical evaluation as it prepares to release results from its Phase 2 study on a treatment for moderate-to-severe eczema, known...
Healthcare costs are escalating, creating a pressing need for insurance providers to enhance care quality while maintaining efficiency. According to Patrick Gordon, CEO of Rocky Mountain...
A recent discovery in Denmark has provided significant insights into ancient medical practices, specifically those used by Vikings. Archaeologists unearthed a male skull dating back over...
Daiichi Sankyo has commenced the first-in-human clinical trial for its investigational drug DS3790, targeting patients with relapsed or refractory B-cell non-Hodgkin lymphoma. The initial patient was...
On February 4, 2026, individuals across the globe are encouraged to engage with their daily horoscopes, which offer insights into potential opportunities and challenges. The Universal...
The landscape for psilocybin therapy in Colorado is rapidly evolving, as the state introduces a variety of licensed facilities for psilocybin-assisted therapy. Following the initial licensing...
Heart disease continues to be the leading cause of death in the United States, as highlighted in a recent report from the American Heart Association. Cardiovascular...
